Impact of the homogeneous and heterogeneous risk factors on the incidence and survival outcome of bone metastasis in NSCLC patients
- 36 Downloads
Bone metastases (BM) is reported as the most frequent distant metastasis in non-small cell lung cancer (NSCLC), but the risk factors for the incidence and prognosis of BM patients in NSCLC have not been extensively elucidated. This study aimed to find risk factors to predict BM patients’ morbidity and survival outcome in NSCLC.
63,505 patients of NSCLC in the Surveillance, Epidemiology and End Results database diagnosed from 2010 to 2015 were used to analyze risk factors for developing BM by conducting multivariable logistic regression. Of these patients, 6152 and 5664 BM patients diagnosed between 2010 and 2014 were selected to investigate predictive factors for BM overall survival (OS) and cancer-specific survival (CSS) using the multivariable Cox proportional hazards regression.
There were overall 7486 (11.79%) BM patients in NSCLC. The homogeneous risk factors for BM patients’ morbidity and survival outcome included male, higher T stage, lymph node involvement, poor differentiation grade, brain metastases, and liver metastases. Married status, adenocarcinoma type and lung metastases were positively correlated with BM incidence, while older age, white race, unmarried status, and SCC and other NSCLC types could predict poor OS and CSS of BM in NSCLC.
The homogeneous and heterogeneous risk factors for morbidity and survival outcome of BM patients could help physicians in more precise and individualized screening and therapies for BM patients in NSCLC.
KeywordsNon-small cell lung cancer Bone metastasis Risk factors Morbidity Prognosis
Non-small cell lung cancer
The United States
Surveillance, epidemiology and end results
National comprehensive cancer network
Median survival time
This study would like to thank the author’s lover Yue Zhang for her love, support and encouragement.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no competing interests.
- Morgensztern D, Waqar S, Subramanian J, Gao F, Trinkaus K, Govindan R (2012) Prognostic significance of tumor size in patients with stage III non-small-cell lung cancer: a surveillance, epidemiology, and end results (SEER) survey from 1998 to 2003 J Thorac Oncol 7:1479–1484. https://doi.org/10.1097/JTO.0b013e318267d032 CrossRefGoogle Scholar
- Siegel RL, Miller KD, PhD AJD (2018) Cancer statistics, 2018 CA: Cancer J Clin 68:11Google Scholar